View Older Stories View More Recent Stories
-
Tobacco stocks soar on FDA guidance
-
Jefferies sees FDA's fruit-flavoured eVape approval as positive for BAT
-
Trump pressures FDA chief on flavored vape approvals - WSJ
-
Altria (MO) PT Raised to $71 at Morgan Stanley
-
Altria Group (MO) Tops Q1 EPS by 7c; offers guidance
-
Barclays reports US tobacco data shows cigarette volume decline
-
FDA applications for nicotine pouches like Zyn, Velo delayed despite fast-track scheme amid concerns over risks to non-users, kids - Reuters
-
BofA on Tobacco: 'Legal US vapor $ sales -16% YoY for the 4- wks ended March 21'
-
Stifel on Altria (MO): 'Solid Combustibles Outlook'
-
Stifel on Altria Group (MO): 'cigarette Volume Decline Rate Improving'
-
Altria Group (MO) Misses Q4 EPS by 2c, Beats on Revenue; Offers Guidance
-
UBS Upgrades Altria (MO) to Buy
-
Altria Group (MO) call put ratio 11.5 calls to 1 put with a focus on December 60 and 61 calls
-
Bernstein's U.S. Consumer Strategy - 'Should We Prepare for a Positive Sector Rotation?'
-
Altria (MO) PT Lowered to $47 at Jefferies
-
Altria (MO) PT Lowered to $61 at UBS
-
Altria Group (MO) Tops Q3 EPS by 1c; offers guidance
-
Altria Group (MO) call put ratio 1.5 calls to 1 put into quarter results
-
British American Tobacco Postpones Plan To Launch Unlicensed Vape In US, Reynolds Spokesperson Says - Reuters
-
Altria director George Muñoz to retire from board after 20 years
-
Altria partners with KT&G for nicotine and wellness products expansion
-
Altria (MO) PT Raised to $72 at BofA Securities
-
Altria (MO) PT Raised to $72 at Stifel
-
Altria Group (MO) Raises Quarterly Dividend 3.9% to $1.06; 6.3% Yield
-
Increasing unusual call option volume: JBS GDRX XNET ALTS IQ IPA OPEN PGEN SQNS MO MSOX
-
Altria (MO) PT Raised to $64 at BofA Securities
-
Altria Group (MO) Tops Q2 EPS by 6c; offers guidance
-
Altria Group (MO) call put ratio 1.7 calls to 1 put into quarter results
-
Altria Group (MO) call put ratio 5.7 calls to 1 put with a focus on July 25 weekly 60 calls into quarter results
-
FDA Authorizes Juul Vaporizer, Refill Cartridges - WSJ
-
Jefferies Starts Altria (MO) at Underperform
-
UBS Upgrades Altria (MO) to Neutral
-
What stocks and implied dividends may indicate when it comes to recession risk
-
Altria Group (MO) Declares $1.02 Quarterly Dividend; 7.1% Yield
-
Altria (MO) PT Raised to $63 at Stifel
-
Altria Group (MO) Tops Q1 EPS by 4c; offers guidance
-
Altria Group (MO) call put ratio 3.4 calls to 1 put into quarter results
-
Goldman: 'We expect call buying to be an unusually profitable strategy this earnings season for three reasons'
-
Altria Group (MO) shares dip slightly after US Supreme Court ruling
-
Altria (MO) PT Raised to $46 at UBS
-
Citi Reiterates Neutral Rating on Altria (MO)
-
Altria Group (MO) call put ratio 10 calls to 1 put with a focus on February 28 weekly 57 calls and February 28 weekly 54 puts
-
Citi Reiterates Neutral Rating on Altria (MO)
-
Stifel Reiterates Buy Rating on Altria (MO)
-
Altria (MO) PT Lowered to $61 at BofA Securities
-
Altria Group (MO) Reports In-Line Q4 EPS; offers guidance
-
Altria Group (MO) Appoints Richard S. Stoddart to its Board
-
Altria Group (MO) Reports Q4, Announces $1B Share Buyback
-
Altria Group (MO) call put ratio 5.4 calls to 1 put with a focus on January 31 weekly calls into quarter results
-
Menthol Cigarette Ban Withdrawn By Trump Administration - Bloomberg
